Skip to content

Clinical trials

Completed Obesity trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Obesity Status: Completed Country / region: Czechia Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20041
20071
20111
20123
20142
20151
20161
20174
20183
20191
20201
20212
20223
20237
20244

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed36

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S5
Eli Lilly and Company4
University Hospital Ostrava4
Boehringer Ingelheim3
Charles University, Czech Republic3
Gelesis, Inc.3
Spatz FGIA, Inc2
Amgen1
Bispebjerg Hospital1
Endobar Solutions LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity36
Overweight11
Diabetes Mellitus, Type 210
Diabetes Mellitus4
Insulin Resistance3
Obesity, Morbid3
Weight Loss2
Cardiovascular Diseases1
Chronic Disease1
Fatigue1

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.